Pratik Shah - Jun 27, 2023 Form 4 Insider Report for ARS Pharmaceuticals, Inc. (SPRY)

Role
Director, 10%+ Owner
Signature
/s/ Kathleen Scott, Attorney-in-Fact
Stock symbol
SPRY
Transactions as of
Jun 27, 2023
Transactions value $
$0
Form type
4
Date filed
6/28/2023, 09:00 PM
Previous filing
Feb 3, 2023
Next filing
Sep 5, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SPRY Stock Option (right to buy) Award $0 +40K $0.00 40K Jun 27, 2023 Common Stock 40K $6.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest in full on the earlier of June 27, 2024 or the date of the Issuer's 2024 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors.